🟢 OPTH surges as company completes psilocybin export to Australia and quiet period ends

Optimi Health Corp. (OPTH) is trading 8.5% up at $4.83, extending a two-day rebound.

• The surge follows the company's announcement on June 29, 2026, of its successful third commercial shipment of 5mg psilocybin capsules to Australia for treatment-resistant depression.
• Additionally, the company's quiet period ended on June 29, 2026, allowing underwriters to initiate research, which could increase investor interest.
• The stock gained 8.8% in the previous session, closing at $4.45.